共 50 条
- [4] Faricimab in diabetic macular oedema: One-year results from the phase 3 RHINE and YOSEMITE trials CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 49 (08): : 834 - 834
- [7] Efficacy, Durability, and Safety of Faricimab in Patients From Asian Countries With Diabetic Macular Edema: 1-Year Subgroup Analysis of the Phase III YOSEMITE and RHINE Trials ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2023, 12 (05): : 451 - 459
- [8] YOSEMITE and RHINE Phase 3 Randomized Clinical Trials of Faricimab for Diabetic Macular Edema: Study Design and Rationale OPHTHALMOLOGY SCIENCE, 2022, 2 (01):
- [10] Improved anatomical control with faricimab in the phase 3 YOSEMITE/RHINE trials in diabetic macular oedema CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (09): : 934 - 935